Table 1 Ten studies of HPD involved radiotherapy
Year | Author | Tumor types | The number of cases of HPD | Radiotherapy strategy | Type of ICB | Relationship between radiotherapy and HPD |
|---|---|---|---|---|---|---|
2016 | Champiat [9] | Solid tumors | 12 | Not described | Anti-PD-1 Anti-PD-L1 | Unrelated |
2016 | Alexander [14] | Renal cancer | 1 | 20Â Gy in 5 fractions | Anti-PD-1 | Unrelated |
2017 | Kato [15] | Endometrial stromal sarcoma | 1 | SBRT | Anti-PD-1 | Not described |
| Â | Â | Breast cancer | 1 | Not described | Anti-PD-1 | Not described |
2017 | Saâda-Bouzid [13] | Head and neck cancers | 10 | Not described | Anti-PD-1 Anti-PD-L1 | Related |
2017 | Yoshida T [16] | Lung cancer | 1 | 60Â Gy | Anti-PD-1 | Related |
2018 | Ogata [17] | Gastric cancer | 1 | 50.4Â Gy in 28 fractions | Anti-PD-1 | Related |
2018 | Du [18] | Lung cancer | 1 | 8Â Gy in 1 fraction | Anti-PD-1 | Related |
2018 | Ferrara [12] | Lung cancer | 56 | Not described | Anti-PD-1 Anti-PD-L1 | Not described |
2019 | Yilmaz [19] | Melanoma | 1 | Not described | Anti-PD-1 | Related |
2019 | Bosch-Barrera [20] | Lung cancer | 1 | 8Â Gy in 1 fraction | Anti-PD-L1 | Not described |